UPC Analytics
DEEN
Übersicht · Eingereicht:

UPC_APP_17291/2025

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Prozessuale & UnteranträgeSonstige prozessualeMunich LDGeneric application
  • 2025-05-08Nur prozessualproceduralGeneric application

    Lengthy procedural order from Munich Local Division in consolidated infringement proceedings by Sanofi entities against multiple generic pharmaceutical companies (Accord, STADA, Dr. Reddy's, Zentiva) concerning EP 2 493 466 (insulin glargine). The order (judge-rapporteur Zigann) addresses numerous procedural matters including damages assessment timing, stay pending EPO Board of Appeal proceedings, and schedule for further pleadings. No substantive ruling; oral hearing deferred to await EPO BoA outcome.